بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

csl behring ag - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 250 ml - the definitive treatment of major hemorrhage is the transfusion of red blood cells restoring a normal oxygen transport capacity of the blood. since, however, the life-threatening event in major hemorrhage is the loss of blood volume and not the erythrocyte deficit, the blood volume can, as an emergency measure, be supported by alburx® 5, albumin (human) 5% solution or another rapidly acting plasma substitute if blood is not immediately available. this will restore cardiac output and abolish circulatory failure with tissue anoxia. though a four- to fivefold volume of crystalloids may be equally effective, their administration takes more time and creates a general overload with sodium and water. in the presence of dehydration, electrolyte solutions such as ringer's lactate should be administered in conjunction with albumin. apart from damage to the respiratory tract, the development of burn shock is the most life-threatening event in the immediate care of the burned patient. therapy during the first 24 hours i

كندا - الإنجليزية - Health Canada

grifols therapeutics llc - albumin (human) - solution - 5% - albumin (human) 5% - blood derivatives

كندا - الإنجليزية - Health Canada

grifols therapeutics llc - albumin (human) - solution - 25% - albumin (human) 25% - blood derivatives

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

baxalta innovations gmbh - plasma protein containing at least 95% human albumin - solution for infusion - 50 gram(s)/litre - blood substitutes and plasma protein fractions; albumin - plasma substitutes and plasma protein fractions - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

baxalta innovations gmbh - plasma protein containing at least 95% human albumin - solution for infusion - 200 gram(s)/litre - blood substitutes and plasma protein fractions; albumin - plasma substitutes and plasma protein fractions - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 10 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used.1,2,3 acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. albutein® 20% can be used in such cases.1 albutein 20% may be of value in the treatment of shock or hypotension in renal dialysis patients.1 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid.4,5,6 albutein 20% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics.1,2,7 albutein 20% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when albumin deficit is the result of excessive protein lo

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used. [1,2,3] acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. albutein 25% can be used in such cases. [1] albutein 25% may be of value in the treatment of shock or hypotension in renal dialysis patients. [1] preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid. [4,5,6] albutein 25% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics. [1,2,7] albutein 25% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when albumin deficit is the result of excessi

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 250 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used.1,2,3 acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. albutein 5% can be used in such cases.1 albutein 5% may be of value in the treatment of shock or hypotension in renal dialysis patients.1 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid.4,5,6 albutein 5% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when albumin deficit is the result of excessive protein loss, the effect of albutein 5% administration will be temporary unless the underlying disorder is reversed.7,8,9 septic patients and patients undergoing major surgery may